Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 5/20 | 0.40 |
| ▸ | MAP3K12 | Q12852 | 10/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.39 |
| ▸ | PIK3R1 | P27986 | 2/20 | 0.39 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627432 | 0.94 | RET (0.40) | RETMAP3K12PIK3CAPIK3R1 | |
| SCHEMBL626123 | 0.94 | RET (0.43) | RETMAP3K12PIK3CAPIK3R1 | |
| SCHEMBL625422 | 0.90 | PIK3CA (0.42) | RETMAP3K12PIK3CAF2RL3 | |
| SCHEMBL627019 | 0.87 | PIK3CA (0.47) | RETMAP3K12HDAC1HDAC2PIK3CA | |
| SCHEMBL625408 | 0.85 | MAP4K1 (0.39) | MAP3K12PIK3CA | |
| SCHEMBL627309 | 0.85 | MAP3K12 (0.46) | MAP3K12PIK3CA | |
| SCHEMBL626243 | 0.84 | MAP3K12 (0.46) | MAP3K12PIK3CAPIK3R1F2RL3 | |
| SCHEMBL626246 | 0.82 | MAP3K12 (0.40) | MAP3K12PIK3CA | |
| SCHEMBL625459 | 0.82 | MAP3K12 (0.41) | MAP3K12PIK3CAF2RL3 | |
| SCHEMBL627431 | 0.82 | PIK3CA (0.48) | PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |